- 期刊
- OpenAccess
Application of Stereotactic Ablative Radiotherapy in Hepatocellular Carcinoma Patients with Child-Turcotte-Pugh Class B Liver Function
摘要
Background: The aim of this study is to evaluate the outcomes and prognostic factors in patients with hepatocellular carcinoma (HCC) and Child-Turcotte-Pugh (CTP) class B liver function after stereotactic ablative radiotherapy (SABR). Materials and Methods: This retrospective study evaluated patients with HCC and impaired liver function who underwent SABR between December 2007 and August 2016. All patients had CTP class B liver function before treatment. Local control (LC) rate, overall survival (OS) rate, prognostic factors, and radiation‑related toxicity were evaluated. Results: This study included 34 patients. The majority had a CTP score of B7 (52.9%) and advanced HCC (91.2%). The median survival time was 4.8 months, and the 1‑year OS rate was 21.4%. Only the tumor number (multiple vs. single) was identified as an independent predictor of survival. The 1-year LC rate was 95.8%. Eight patients (23.5%) developed the radiation‑induced liver disease, and 15 (44.1%) had a CTP score decline of ≥2 within 3 months. Other toxicities were generally tolerable. Conclusion: SABR may be considered as an alternative option for patients with HCC and CTP class B liver function, particularly for those with a single lesion.
延伸閱讀
- Cescon, M., Ravaioli, M., Grazi, G. L., Ercolani, G., Cucchetti, A., Bertuzzo, V., Vetrone, G., Gaudio, M. D., Vivarelli, M., Grigioni, A. D., Dazzi, A., Gioia, P. D., Lauro, A., & Pinna, A. D. (2010). Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma. Journal of Transplantation, 2010(), 133-140. https://doi.org/10.1155/2010/904152
- Campbell, S. P., Song, D. Y., Pierorazio, P. M., Allaf, M. E., & Gorin, M. A. (2015). Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma. Journal of Oncology, 2015(), 36-41. https://doi.org/10.1155/2015/547143
- Chengt, J. C. U., Wu, J. K., Huang, J. C. M., Cheng, S. H., Huang, D., Jian, J. J. M., & Yang, P. S. (1999). Dose-Volume Analysis for 4 Patients with Radiation-Induced Liver Disease after 3-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma. 放射治療與腫瘤學, 6(1), 55-61. https://doi.org/10.6316/TRO/199906(1)55
- Wang, P. M., Hsu, W. C., Ying, K. S., Chen, S. J., Chao, C. J., Huang, J. C., & Lin, G. D. (2002). Hyperfractionated Three-dimensional Conformal Radiotherapy for Small Hepatocellular Carcinoma：A Pilot Study. 中華放射線醫學雜誌, 27(6), 281-287. https://www.airitilibrary.com/Article/Detail?DocID=10188940-200212-27-6-281-287-a
- Yang, J. F., Lo, C. H., Lin, C. S., Chao, H. L., Lin, K. T., Chen, C. M., & Huang, W. Y. (2017). FACTORS ASSOCIATED WITH RADIOGRAPHIC RESPONSE AND OVERALL SURVIVAL AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN TUMOR THROMBOSIS. 放射治療與腫瘤學, 24(1), 13-23. https://doi.org/10.6316/TRO/201724(1)13